Keywords: amersham, reports, new, visipaque, data, uk, biotechnology

Amersham reports new Visipaque data

Article | 17 February 2003

UK biotechnology company Amersham has reported positive clinical trialresults for its third-generation X-ray contrast agent, Visipaque (iodixanol), which should help ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amersham

Go to company listing